Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis

Author(s):

David M.P. De Oliveira, Lisa Bohlmann, Trent Conroy, Freda E.C. Jen, Arun Everest-Dass, Karl A. Hansford, Raghu Bolisetti, Ibrahim M. El-Deeb, Brian M. Forde, Minh Duy Phan, Jake A. Lacey, Aimee Tan, Tania Rivera-Hernandez, Stephan Brouwer, Nadia Keller, Timothy J. Kidd, Amanda J. Cork, Michelle J. Bauer, Gregory M. Cook, Mark R. Davies, Scott A. Beatson, David L. Paterson, Alastair G. McEwan, Jian Li, Mark A. Schembri, Mark A.T. Blaskovich, Michael P. Jennings, Christopher A. McDevitt, Mark Von Itzstein, Mark J. Walker

Details:

Science Translational Medicine, Volume 12, Issue 570, 2020-11-01, Article number abb3791

Article Link: Click here

Affiliations:

• The University of Queensland
• Monash University
• Griffith University
• University of Otago
• Department of Microbiology & Immunology
• UMAE Hospital de Especialidades Centro Medico Nacional Siglo XXI